Company Name or Ticker Symbol
Search for other Categories

Supernus Pharmaceuticals Inc  (SUPN)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations


Supernus Pharmaceuticals Inc

SUPN's Financial Statements and Analysis

Supernus Pharmaceuticals Inc reported in I. Quarter net earnings per share of $0.19 an increase by 0 % year on year from $0.08 and decline of 0 % from $0.26 earned in IV. Quarter (Dec 31 2016).

Supernus Pharmaceuticals Inc's Revenue rose by % in I. Quarter (Mar 31 2017) year on year, to $58 million and declined by -7.69 % sequentially.

Supernus Pharmaceuticals Inc is
More on SUPN's Income Statement

I. Quarter
Earnings Per Share Revenues
$ 0.19 $  58 Mill
$+0.11     +137.5 % $+13M     +30.28 %
You need to upgrade your Flash Player

Supernus Pharmaceuticals Inc's net income of $10 million in I. Quarter increased by 113.41 % from net earnings of $5 million achieved in I. Quarter a year ago.

Sequentially net earnings fell by -28.09 % from net income of $14.32 million realized in previous quarter.

More on SUPN's Growth

Inventories Inventories grew by 46.94 % to $19 million from I. Quarter a year ago, sequentially inventories rose by 14.08 %. In I. Quarter company's net cash and cash equivalents decreased by $-7 million, capital expenditures fell by 418.60%, to $-4 millions compare to same quarter a year ago and rose by -80.61% from IV. Quarter (Dec 31 2016).

More on SUPN's Cash flow Statement

Supernus Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Supernus Pharmaceuticals Inc earned $ 1.57 cash per share, on a free-cash flow basis 86.62 % of net earning per share.

Book value grew by -310.11 % sequentially to $3.91 per share, 110.88% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 3.35 per share from $ -1.70.

Company issued 155.93 million shares or -151.15 % in I. Quarter.
Interest Coverage Ratio was 118.94. Debt Coverage Ratio was 13.11.

More on SUPN's Dividends
 Market Capitalization (Millions) 2,232
 Shares Outstanding (Millions) 53
 Total Debt (Millions $) 3
 Revenue (TTM) (Millions $) 228
 Net Income (TTM) (Millions $) 97
 Cash Flow (TTM) (Millions $) 40
 Capital Exp. (TTM) (Millions $) -23
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com